CS166256B2 - - Google Patents

Info

Publication number
CS166256B2
CS166256B2 CS2693A CS269370A CS166256B2 CS 166256 B2 CS166256 B2 CS 166256B2 CS 2693 A CS2693 A CS 2693A CS 269370 A CS269370 A CS 269370A CS 166256 B2 CS166256 B2 CS 166256B2
Authority
CS
Czechoslovakia
Application number
CS2693A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS166256B2 publication Critical patent/CS166256B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Clamps And Clips (AREA)
CS2693A 1969-04-21 1970-04-21 CS166256B2 (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81805769A 1969-04-21 1969-04-21

Publications (1)

Publication Number Publication Date
CS166256B2 true CS166256B2 (ko) 1976-02-27

Family

ID=25224552

Family Applications (1)

Application Number Title Priority Date Filing Date
CS2693A CS166256B2 (ko) 1969-04-21 1970-04-21

Country Status (9)

Country Link
US (1) US3502663A (ko)
AT (1) AT296503B (ko)
BR (1) BR6914873D0 (ko)
CH (1) CH529789A (ko)
CS (1) CS166256B2 (ko)
ES (1) ES378831A1 (ko)
NO (1) NO135067C (ko)
PL (1) PL80656B1 (ko)
SE (1) SE361044B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL149810B (nl) * 1969-04-21 1976-06-15 Lilly Co Eli Werkwijze ter bereiding van een farmaceutisch preparaat door kristallijn cefalexine in een voor therapeutische toediening geschikte vorm te brengen, gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van voor bovengenoemde toepassing geschikt cefalexine.
GB1317159A (en) * 1969-09-26 1973-05-16 Glaxo Lab Ltd Manufacture of cephalosporin compounds
IT1126544B (it) * 1979-12-07 1986-05-21 Dobfar Spa Procedimento per la preparazione di derivati dell'acido 7-amino-desacetossi cefalosporanico
JPS60231683A (ja) * 1984-05-02 1985-11-18 Teijin Ltd セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤
US5278157A (en) * 1989-07-10 1994-01-11 Gema, S.A. Stable cephradine hydrate
US5374719A (en) * 1993-06-04 1994-12-20 Eli Lilly And Company Process for converting loracarbef dihydrate to loracarbef monohydrate
US5352782A (en) * 1993-06-04 1994-10-04 Eli Lilly And Company Process for preparing crystalline β-lactam monohydrate
US5399686A (en) * 1993-06-04 1995-03-21 Eli Lilly And Company Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate
US5580977A (en) * 1995-03-01 1996-12-03 Eli Lilly And Company Process for preparing loracarbef monohydrate

Also Published As

Publication number Publication date
SE361044B (ko) 1973-10-15
CH529789A (de) 1972-10-31
PL80656B1 (en) 1975-08-30
NO135067B (ko) 1976-10-25
AT296503B (de) 1972-02-25
US3502663A (en) 1970-03-24
ES378831A1 (es) 1973-01-16
BR6914873D0 (pt) 1973-03-08
NO135067C (ko) 1977-02-02

Similar Documents

Publication Publication Date Title
AU2270770A (ko)
AU465452B2 (ko)
AU429630B2 (ko)
AU450150B2 (ko)
AU2355770A (ko)
AU442375B2 (ko)
AU427401B2 (ko)
AU470301B1 (ko)
AU442463B2 (ko)
AU442554B2 (ko)
AU428129B2 (ko)
AU428131B2 (ko)
AU417208B2 (ko)
AU470661B1 (ko)
AU438128B2 (ko)
AU425297B2 (ko)
AU442285B2 (ko)
AU442322B2 (ko)
AU442357B2 (ko)
AU414607B2 (ko)
AU442380B2 (ko)
AU410358B2 (ko)
AU442535B2 (ko)
AU442538B2 (ko)
AU5077469A (ko)